BridgeMD
New treatment option for Nutrition Disorder, Infant
Official title Nutritional Intervention for Biliary Atresia
ClinicalTrials.gov ID: NCT06764082
What this study is testing
- What it's testing
- Infants with biliary atresia (Biliary atresia, BA) have an increased risk of malnutrition due to insufficient dietary intake to maintain normal growth, impaired intestinal absorption, increased metabolic rate, and damage to some liver macronutrient metabolic pathways. The medium-chain triglyceride formula (MCT) in enteral nutrition has advantages: (1) It has a fast metabolism in the liver and possesses the advantage of being an innate energy source; (2) It can share metabolic pathways with some other fatty acids (DHA, EPA), and can promote the synthesis of phospholipids, etc.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 3
You may be able to join if
- Infants under 3 months old;
- Children clinically diagnosed with biliary atresia and in need of Kasai surgery;
- The patient themselves, legal representative or guardian have signed the informed consent form and are willing to actively cooperate with treatment...
You likely can't join if
- Low birth weight infants or very low birth weight infants;
- Complicated with life-threatening diseases of various organ systems;
- Complicated with other severe digestive tract malformations or other diseases that may interfere with the treatment of the patient or the patient's...
- Patients who have participated in other clinical trials within the last month;
- Any other conditions that the researcher deems unsuitable for participation in this trial.
The study team makes the final eligibility decision.
Where it's taking place
- Wuhan, Hubei, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 day to 3 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wuhan, Hubei, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.